Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without...

Area of Science:

• Cardiovascular Medicine
• Medical Risk Assessment
• Lipidology

Background:

• Cardiovascular disease (CVD) risk prediction is crucial for patient management.
• Dyslipidaemia is a significant risk factor for CVD.
• Existing risk calculators, like Framingham and PROCAM, are widely used but may have limitations.

Purpose of the Study:

• To compare the performance of the Framingham Risk Score and the Prospective Cardiovascular Munster (PROCAM) study risk equations.
• To evaluate the impact of family history and triglyceride levels on risk prediction.
• To assess the implications for potential overtreatment in dyslipidaemic patients.

Main Methods:

• Risk calculations were performed for 234 dyslipidaemic patients without diagnosed vascular disease.
• Analyses included subgroups and the effect of incorporating family history (FaHist).
• Triglyceride (TG) levels were adjusted to 1.7 mmol/l for comparative analysis.

Main Results:

• Framingham risk was significantly higher than PROCAM risk across various subgroups, even after adjusting TG levels.
• The proportion of patients with a coronary heart disease (CHD) risk >= 20% was higher with Framingham (21.4-23.1%) than PROCAM (16.2%).
• Framingham scores were notably higher than PROCAM when family history was included, particularly in higher-risk tertiles and in men.

Conclusions:

• The Framingham equation predicts a substantially higher cardiovascular risk than PROCAM in dyslipidaemic individuals.
• This discrepancy may lead to overtreatment with the Framingham model, while PROCAM might also overestimate risk.
• There is a critical need for more accurate risk prediction models for dyslipidaemic patients without overt vascular disease.